With President Donald Trump’s executive order to reschedule cannabis, businesses in the industry are rolling out their growth strategies.

Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.

U.S. home prices climbed 0.2% month over month in November on a seasonally adjusted basis, slightly smaller than October's 0.3% monthly increase. That's according to a new report from Redfin, the real ...

For decades, schizophrenia and bipolar disorder have been diagnosed from the outside in, through behavior, mood, and memory ...

Both Novo Nordisk NVO and Amgen AMGN are large-cap, innovation-driven healthcare leaders with global scale, strong balance ...

Cardinal Health leads Zacks' list of large-cap MedTech stocks as AI adoption, robotics and rising procedure volumes set up continued gains in 2026.

Some requests by reviewers to cite their own publications are coercive and can unnecessarily delay indexation and publication.

If you are looking at ABIVAX Société Anonyme and wondering whether the huge run up has left any value on the table, you are not alone. This stock has gone from niche biotech to serious talking point ...

Background Malnutrition influences prognosis in patients with heart failure, but current nutritional evaluation methods are ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses about the answer to this question.

An asset purchase agreement has been signed with Dexcel Pharma USA, which will acquire the full rights to Zubsolv® in the US, at a purchase price of USD 91 million plus the value of inventory at closi ...

Introduction This article outlines the research protocol for a multicentre, randomised, controlled study designed to evaluate the therapeutic effect of a modified olfactory training (MOT) based on ...